AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 480048 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 15 mg/kg
Number of subjects: 0
Study 480048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31735246 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 111
Study 31735246 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 111
Study 28292751 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation plus ICD implantation
Number of subjects: 111
Study 28292751 — intervention group
Group type: COMPARATOR
Intervention: ICD implantation without catheter ablation (ICD-only group)
Number of subjects: 111
Study 28292751 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 111
Study 26460992 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) or chemoradiation (CRT)
Number of subjects: 253
Study 26460992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean dose to the oral mucosa
Number of subjects: 253
Study 26460992 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy
Number of subjects: 253
Study 26460992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean dose to the inferior constrictor (IC)
Number of subjects: 253
Study 23652274 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic training prior to strength-endurance exercise program
Number of subjects: 34
Study 23652274 — intervention group
Group type: COMPARATOR
Intervention: Control group with placebo air mixture
Number of subjects: 34
Study 21283158 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density silicone oil (HDSO) as an internal retinal tamponade after vitrectomy
Number of subjects: 41
Study 18957534 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (MUFA) diet
Number of subjects: 124
Study 18957534 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate (CHO) diet
Number of subjects: 124
Study 17916877 — intervention group
Group type: COMPARATOR
Intervention: 10 mg metoclopramide as a slow intravenous infusion over 15 min (SIG group)
Number of subjects: 120
Study 17916877 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide intravenous bolus infusion over 2 min (BIG group)
Number of subjects: 120
Study 17916877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SIG and BIG)
Number of subjects: 120
Study 16026005 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 35
Study 16026005 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 35
Study 16026005 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 35
Study 11982466 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy guided by preoperative lymphoscintigraphy
Number of subjects: 2000
Study 9619011 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous warm blood cardioplegia with normothermic CPB
Number of subjects: 20
Study 9619011 — intervention group
Group type: COMPARATOR
Intervention: Intermittent perfusion of cold crystalloid (St. Thomas Hospital solution) with hypothermic CPB
Number of subjects: 20
Study 7713856 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 100 mg b.i.d.
Number of subjects: 32
Study 7713856 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden 2 mg b.i.d.
Number of subjects: 32
Study 7713856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 2502974 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid rectal suppository (500 mg)
Number of subjects: 6
Study 2502974 — intervention group
Group type: COMPARATOR
Intervention: Oral valproate sodium syrup (500 mg)
Number of subjects: 6
Study 776351 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 60 mg/day
Number of subjects: 24
Study 776351 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg/day
Number of subjects: 24
Study 776351 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 240 mg/day
Number of subjects: 24
Study 776351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30431297 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 166
Study 30431297 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 166
Study 30431297 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Therapy (CT) and Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 166
Study 30431297 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice of therapy-acquired regulatory skills
Number of subjects: 166
Study 28831733 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-surgical pulmonary rehabilitation (PR) program (exercise, diet, and psychological intervention) for 12 weeks
Number of subjects: 4
Study 28831733 — intervention group
Group type: COMPARATOR
Intervention: Bariatric surgery only (Control group)
Number of subjects: 4
Study 25139056 — intervention group
Group type: EXPERIMENTAL
Intervention: MTAU plus five sessions of graded body image exposure
Number of subjects: 45
Study 25139056 — intervention group
Group type: COMPARATOR
Intervention: Maintenance treatment as usual (MTAU) only
Number of subjects: 45
Study 23746555 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8mg added to metformin followed by insulin detemir for 52 weeks (RT group)
Number of subjects: 323
Study 23746555 — intervention group
Group type: COMPARATOR
Intervention: Continuation without detemir (RC group)
Number of subjects: 323
Study 23746555 — intervention group
Group type: EXPERIMENTAL
Intervention: Run-in phase with liraglutide and metformin
Number of subjects: 323
Study 21666744 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone (CD)
Number of subjects: 1238
Study 21666744 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 1238
Study 19927363 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoadsorption apheresis (IA) plus immunosuppressive drug therapy (IDT)
Number of subjects: 17
Study 19927363 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive drug therapy (IDT) only
Number of subjects: 17
Study 16796126 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginosacral colpopexy (VSC)
Number of subjects: 32
Study 15164115 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status evaluation using anthropometry (height, weight, hemoglobin concentration)
Number of subjects: 1655
Study 15164115 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural children
Number of subjects: 1655
Study 15164115 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban children
Number of subjects: 1655
Study 15164115 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin concentration measurement
Number of subjects: 1655
Study 12368620 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency thermal ablation of inferior turbinates at 100 kHz with a voltage root mean square value of 168 to 182
Number of subjects: 20
Study 12368620 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency thermal ablation of inferior turbinates
Number of subjects: 20
Study 9445274 — intervention group
Group type: EXPERIMENTAL
Intervention: T-piece trial (T)
Number of subjects: 14
Study 9445274 — intervention group
Group type: EXPERIMENTAL
Intervention: Extubation (E)
Number of subjects: 14
Study 9445274 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETT)
Number of subjects: 14
Study 9445274 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic airway
Number of subjects: 14
Study 8077353 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening calcium supplementation (1000 mg for 14 days)
Number of subjects: 18
Study 8077353 — intervention group
Group type: COMPARATOR
Intervention: Morning calcium supplementation (1000 mg for 14 days)
Number of subjects: 18
Study 2807562 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg administered one hour before ESWL
Number of subjects: 50
Study 2807562 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic (control group)
Number of subjects: 50
Study 773588 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofenate
Number of subjects: 4
Study 773588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31977000 — intervention group
Group type: EXPERIMENTAL
Intervention: AB002 (E‐WE thrombin), <2 µg/kg, IV
Number of subjects: 0
Study 31977000 — intervention group
Group type: EXPERIMENTAL
Intervention: AB002 (E‐WE thrombin)
Number of subjects: 0
Study 31609396 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching to another SSRI or to venlafaxine with cognitive behavioral therapy
Number of subjects: 0
Study 31609396 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching to another SSRI or to venlafaxine without cognitive behavioral therapy
Number of subjects: 0
Study 31609396 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 29846417 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 69
Study 29846417 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 69
Study 26053011 — intervention group
Group type: EXPERIMENTAL
Intervention: CONTOUR PLUS BGMS for fingertip blood tests
Number of subjects: 363
Study 26053011 — intervention group
Group type: EXPERIMENTAL
Intervention: CONTOUR PLUS BGMS for venous blood tests
Number of subjects: 363
Study 26053011 — intervention group
Group type: EXPERIMENTAL
Intervention: CONTOUR PLUS BGMS for precision testing
Number of subjects: 363
Study 25267568 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine EEG
Number of subjects: 399
Study 23290112 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month neoadjuvant hormonal therapy (NHT) before (125)I permanent seed implantation
Number of subjects: 165
Study 23290112 — intervention group
Group type: COMPARATOR
Intervention: (125)I permanent seed implantation
Number of subjects: 165
Study 21067382 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein hydrolysate formula
Number of subjects: 230
Study 21067382 — intervention group
Group type: COMPARATOR
Intervention: Conventional, cow's‐milk‐based formula (control)
Number of subjects: 230
Study 17579840 — intervention group
Group type: EXPERIMENTAL
Intervention: ropinirole 0.5 mg
Number of subjects: 12
Study 17579840 — intervention group
Group type: EXPERIMENTAL
Intervention: ropinirole 0.25 mg
Number of subjects: 12
Study 17579840 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 15956965 — intervention group
Group type: EXPERIMENTAL
Intervention: ZD4054 (single oral dose)
Number of subjects: 36
Study 15956965 — intervention group
Group type: COMPARATOR
Intervention: ZD4054 (ascending single-dose)
Number of subjects: 36
Study 11860422 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamond laser scalpel combined with CO2 laser
Number of subjects: 10
Study 11860422 — intervention group
Group type: COMPARATOR
Intervention: Free beam CO2 laser
Number of subjects: 10
Study 10432325 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime plus intravenous albumin
Number of subjects: 126
Study 10432325 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 126
Study 8560415 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 1171
Study 8560415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1171
Study 2265052 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg wrapping with elasticated Esmarch bandages
Number of subjects: 24
Study 2265052 — intervention group
Group type: COMPARATOR
Intervention: Control (no leg wrapping)
Number of subjects: 24
Study 7437242 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacrinone (MK-196) 60 mg
Number of subjects: 15
Study 7437242 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacrinone (MK-196) 40 mg
Number of subjects: 15
Study 7437242 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacrinone (MK-196)
Number of subjects: 15
Study 31860107 — intervention group
Group type: EXPERIMENTAL
Intervention: Concept group (explicit conceptual instruction regarding diagnostic testing and bayesian revision)
Number of subjects: 61
Study 31860107 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience group (exposure to repeated examples of cases with feedback regarding posttest probability)
Number of subjects: 61
Study 31860107 — intervention group
Group type: COMPARATOR
Intervention: Control group (no conceptual instruction or repeated examples)
Number of subjects: 61
Study 28539065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon-style handout
Number of subjects: 93
Study 28539065 — intervention group
Group type: COMPARATOR
Intervention: Traditional-style handout
Number of subjects: 93
Study 24922198 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 58
Study 24922198 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study 24922198 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker
Number of subjects: 58
Study 24302273 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 839
Study 24302273 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 839
Study 22198243 — intervention group
Group type: EXPERIMENTAL
Intervention: CA-125 velocity (average velocity of 19.749 U/ml per month)
Number of subjects: 28038
Study 22198243 — intervention group
Group type: COMPARATOR
Intervention: Non-cancer group (average velocity of 0.035 U/ml per month)
Number of subjects: 28038
Study 22198243 — intervention group
Group type: EXPERIMENTAL
Intervention: CA-125 velocity and time intervals between screenings
Number of subjects: 28038
Study 18923870 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightweight polypropylene mesh
Number of subjects: 25
Study 18923870 — intervention group
Group type: COMPARATOR
Intervention: Heavy polypropylene mesh
Number of subjects: 25
Study 17889549 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral and Maxillofacial Surgery (OMFS) patients
Number of subjects: 600
Study 17889549 — intervention group
Group type: COMPARATOR
Intervention: Control groups (surgical, dental, and general practitioners/internal medicine patients)
Number of subjects: 600
Study 15241768 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program (WSTP)
Number of subjects: 82
Study 15241768 — intervention group
Group type: COMPARATOR
Intervention: Standard undergraduate OT curriculum (Control)
Number of subjects: 82
Study 15241768 — intervention group
Group type: COMPARATOR
Intervention: Fourth-year control group
Number of subjects: 82
Study 12568207 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 30
Study 12568207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg/day
Number of subjects: 30
Study 12568207 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study 9884181 — intervention group
Group type: EXPERIMENTAL
Intervention: St. John's wort
Number of subjects: 0
Study 10670264 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg subarachnoid morphine with bupivacaine (group M)
Number of subjects: 30
Study 10670264 — intervention group
Group type: COMPARATOR
Intervention: Control group (group S)
Number of subjects: 30
Study 10670264 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 1381642 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin (single bolus intravenous injection before catheter insertion)
Number of subjects: 88
Study 1381642 — intervention group
Group type: COMPARATOR
Intervention: No teicoplanin (control group)
Number of subjects: 88
Study 6885575 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic acidosis (induced by ammonium chloride)
Number of subjects: 6
Study 6885575 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory acidosis (induced by 5% CO2 inhalation)
Number of subjects: 6
Study 6885575 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control study)
Number of subjects: 6
Study 6885575 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic alkalosis (induced by sodium bicarbonate)
Number of subjects: 6
Study 31390774 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency Ratio (FR) method
Number of subjects: 71
Study 31390774 — intervention group
Group type: EXPERIMENTAL
Intervention: Information Value Model (IVM) method
Number of subjects: 71
Study 29777144 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia associated with SAM block + PECS I
Number of subjects: 50
Study 29777144 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only
Number of subjects: 50
Study 26817639 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention promoting HPV vaccination and condom use, delivered by school nurses in a 30 min face-to-face structured session.
Number of subjects: 741
Study 24735128 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 μg budesonide
Number of subjects: 20
Study 24735128 — intervention group
Group type: EXPERIMENTAL
Intervention: 720 μg budesonide
Number of subjects: 20
Study 24735128 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,440 μg budesonide
Number of subjects: 20
Study 24735128 — intervention group
Group type: EXPERIMENTAL
Intervention: four repetitive 720-μg budesonide doses
Number of subjects: 20
Study 24735128 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 22421197 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to EMF in incubators
Number of subjects: 28
Study 22421197 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-removal from incubators to cribs
Number of subjects: 28
Study 22421197 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exposed to EMF)
Number of subjects: 28
Study 20819220 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion boost applied to the macroscopic tumor up to a total dose of 18 Gy E in 6 fractions at a single dose of 3 Gy E.
Number of subjects: 0
Study 20819220 — intervention group
Group type: COMPARATOR
Intervention: Proton boost applied up to a total dose of 10 Gy E in 5 single fractions of 2 Gy E.
Number of subjects: 0
Study 20819220 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion boost
Number of subjects: 0
Study 20819220 — intervention group
Group type: COMPARATOR
Intervention: Proton boost
Number of subjects: 0
Study 18814836 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine pancreatic lipase (PPL)
Number of subjects: 0
Study 18814836 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic extracts (PE)
Number of subjects: 0
Study 18814836 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect PPL assay
Number of subjects: 0
Study 16671415 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy
Number of subjects: 0
Study 16671415 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 12732586 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/d) before bedtime
Number of subjects: 100
Study 12732586 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg/d) on awakening
Number of subjects: 100
Study 12732586 — intervention group
Group type: COMPARATOR
Intervention: Nonpharmacological hygienic-dietary recommendations
Number of subjects: 100
Study 10821360 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 12763
Study 10821360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12763
Study 9032748 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose estrogens (0.625 mg of conjugated estrogens)
Number of subjects: 72
Study 9032748 — intervention group
Group type: COMPARATOR
Intervention: Tibolone
Number of subjects: 72
Study 8362899 — intervention group
Group type: EXPERIMENTAL
Intervention: Stamped packets (prepaid postage)
Number of subjects: 325
Study 8362899 — intervention group
Group type: COMPARATOR
Intervention: Unstamped packets (no prepaid postage)
Number of subjects: 325
Study 8362899 — intervention group
Group type: EXPERIMENTAL
Intervention: Stamped packets (indigent patients)
Number of subjects: 325
Study 8362899 — intervention group
Group type: COMPARATOR
Intervention: Unstamped packets (indigent patients)
Number of subjects: 325
Study 8362899 — intervention group
Group type: EXPERIMENTAL
Intervention: Stamped packets (private insurance patients)
Number of subjects: 325
Study 8362899 — intervention group
Group type: COMPARATOR
Intervention: Unstamped packets (private insurance patients)
Number of subjects: 325
Study 3719163 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ultrasound treatment
Number of subjects: 40
Study 3719163 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 29447770 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term dual antiplatelet therapy (DAPT)
Number of subjects: 7242
Study 29447770 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term dual antiplatelet therapy (DAPT)
Number of subjects: 7242
Study 26817879 — intervention group
Group type: EXPERIMENTAL
Intervention: M72/AS01
Number of subjects: 240
Study 26817879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 24521675 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidification using the Fisher & Paykel Healthcare MR880 humidifier
Number of subjects: 210
Study 24521675 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidification in compliant PP patients
Number of subjects: 210
Study 24521675 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidification (HNRQ PP analysis)
Number of subjects: 210
Study 24521675 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no humidification)
Number of subjects: 210
Study 22794532 — intervention group
Group type: EXPERIMENTAL
Intervention: Social and cognitive stressor before the risk-taking battery
Number of subjects: 89
Study 22794532 — intervention group
Group type: COMPARATOR
Intervention: No stress condition (control)
Number of subjects: 89
Study 20458203 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological Inoculation (PI)
Number of subjects: 0
Study 20458203 — intervention group
Group type: COMPARATOR
Intervention: Ventilation
Number of subjects: 0
Study 17651416 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 187
Study 17651416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187